Rieko Ishima is a Hillman Fellow for Innovative Developmental Cancer Research: https://hillmanresearch.upmc.edu/research/for-our-researchers/hillman-fellows
Dr. Ishima and colleagues developed a novel nuclear magnetic resonance system to discover a new class of kinase inhibitors that enhance natural mechanisms of kinase regulation. These so-called “allosteric” inhibitors are anticipated to suppress emergence of resistant tumor cells when combined with existing kinase inhibitor drugs. This project will study the interaction between newly identified inhibitors and Src kinases.
Congratulations Rieko!